Metraipolis › archive › dc_53ba08e205f6
Demographic and Clinical Characteristics of Patients Treated With Lecanemab Stratified by Amyloid-Related Imaging Abnormality Status — Europe PMC PMID:42732414
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42732414
- DOI
- 10.7759/cureus.114472
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T20:21:56.707Z
- SHA-256 of the archived text
be696522632110c1400350de9bf428e64bea45df6e43b769e5de7ffcce3bf59f- Stable URL of this page
https://metraipolis.com/documento/dc_53ba08e205f6
How to cite
Demographic and Clinical Characteristics of Patients Treated With Lecanemab Stratified by Amyloid-Related Imaging Abnormality Status — Europe PMC PMID:42732414 — Europe PMC (en), https://europepmc.org/article/MED/42732414 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_53ba08e205f6 (Metraipolis archive dc_53ba08e205f6, sha256 be696522632110c1400350de9bf428e64bea45df6e43b769e5de7ffcce3bf59f)
BibTeX
@misc{dc53ba08e205f6,
title = {Demographic and Clinical Characteristics of Patients Treated With Lecanemab Stratified by Amyloid-Related Imaging Abnormality Status — Europe PMC PMID:42732414},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42732414},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_53ba08e205f6; sha256 be696522632110c1400350de9bf428e64bea45df6e43b769e5de7ffcce3bf59f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42732414. Agents can read the archived copy with the MCP tool read_document.